Akèy › Amiloidoz Chèn Limyè Imunoglobulin › Kalifòni
Etid klinik pou Amiloidoz Chèn Limyè Imunoglobulin nan Kalifòni
3 etid pou Amiloidoz Chèn Limyè Imunoglobulin ap chèche patisipan nan sit nan Kalifòni.
Tèks ofisyèl etid la (Anglè)
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, San Francisco
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07081646Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06022939Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Cedars-Sinai Medical Center, Los Angeles
- University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Tout sèks · Mizajou Aug 6, 2025 · NCT06365060Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.